FDA approves Akebia Therapeutics’ Vafseo for anaemia caused by CKD
The approval is supported by the safety and efficacy data from the INNO2VATE programme and post-marketing safety data from Japan where Vafseo has been available since August 2020
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
The approval is supported by the safety and efficacy data from the INNO2VATE programme and post-marketing safety data from Japan where Vafseo has been available since August 2020
Chubb today announced the launch of a new HealthTech industry practice in
Recently, Scivita Medical Technology Co., Ltd. ("Scivita Medical") and Boston Scientific Corporation (NYSE: BSX),
Seegene Inc. (KQ096530), a leading South Korean company providing a total solution
Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, announced